Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

PURPOSE To study the impact of transarterial Yttrium-90 radioembolization (TARE) in combination with second-line systemic chemotherapy for colorectal liver metastases (CLM). METHODS In this...

PURPOSE CD19-targeted chimeric antigen receptor (CAR)–modified T cells demonstrate unprecedented responses in B-cell acute lymphoblastic leukemia (B-ALL); however, relapse remains a substantial challenge. Short...

PURPOSE Although the majority of patients with relapsed or refractory large B-cell lymphoma respond to axicabtagene ciloleucel (axi-cel), only a minority of patients have...

PURPOSE To address the role of consolidation treatment for newly diagnosed, transplant eligible patients with multiple myeloma in a controlled clinical trial. PATIENTS AND...

PURPOSE To address the role of consolidation treatment for newly diagnosed, transplant eligible patients with multiple myeloma in a controlled clinical trial. PATIENTS AND...

PURPOSE To address the role of consolidation treatment for newly diagnosed, transplant eligible patients with multiple myeloma in a controlled clinical trial. PATIENTS AND...

PURPOSE Despite extensive randomized evidence supporting the use of treatment breaks in metastatic colorectal cancer (mCRC), they are not universally offered to patients despite...

  • In FOCUS4-N trial in pts with stable or responding mCRC after 16 weeks of first-line therapy, maintenance capecitabine improved PFS compared with active monitoring (HR 0.40; P<0.0001), but not OS (HR 0.93; P=0.66): https://t.co/m0I004pUwQ #CRCSM #medonc - view on twitter

1530 Background: Patients receiving treatment for advanced cancer are at substantial risk for unplanned hospitalization. A validated two-variable risk model can identify patients at...

  • There are a number of tools out there to predict risk for hospitalization during cancer treatment. Some are simple, some complex, but it appears that such tools can add value to unstructured clinician assessment: https://t.co/8stibC1XnO - view on twitter

PURPOSE Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy (IG-IMRT) with three-dimensional conformal...

  • PARCER study reveals that adjuvant image-guided IMRT for cervical cancer is associated with reduced grade ≥2 late toxicities compared with conventional RT (28% vs 49%; HR 0.50; P<0.001), with no difference in disease outcomes (DFS HR 1.03; P = .89): https://t.co/RP4D4ME58k - view on twitter